US Group Raises Pricing Recommendation for Gilead's Remdesivir in Covid-19 June 24, 2020 Get link Facebook X Pinterest Email Other Apps The drugmaker has signed licensing agreements with a bevy of Indian drugmakers including Cipla Ltd and Hetero Labs Ltd. from Top World News- News18.com https://ift.tt/2NvHFtG Comments
The drugmaker has signed licensing agreements with a bevy of Indian drugmakers including Cipla Ltd and Hetero Labs Ltd.
Comments
Post a Comment